410 Medical is dedicated to developing innovative products that help emergency clinicians provide better care for critically ill patients.

Bivarus is a healthcare IT company that has developed an elegant and efficient patient survey platform. Acquired by Press Ganey Associates in January 2018.

Clinipace is a clinical research organization whose services are enhanced by a proprietary on-demand software platform and clinical research services. Acquired by dMed in April 2021.

Contego Medical has developed a platform based on the integration of an embolic protection filter and a treatment device into one single catheter.

GeneCentric Therapeutics is applying proprietary technology to identify drug responder populations that enable the development of precision cancer drugs.

The Company’s lead product candidate, PB2452, is a novel reversal agent for the antiplatelet drug ticagrelor. IPO in October, 2018 (NASDAQ:PHAS)

The SHAPE-MaP technology developed in the lab of Dr. Weeks identifies functional motifs within RNA by mapping the RNA three-dimensional structure.

Stridebio is developing engineered viral vectors for gene therapy. Acquired by Ginkgo Bioworks 2023
